← All agents | ← Research tracker
Telerehabilitation
PubChem entry
Evidence Summary
Evidence Level: Preliminary
Mechanism: Enrollment: Actual, Enrollment: Estimated, Sponsor Type: Network, Sponsor Type: Other
Safety: Limited specific safety data in these populations. Review full prescribing information and consult specialist. Many agents used off-label or investigational.
Dosing: See linked studies/trials for reported doses and durations; typical protocols vary widely.
Investigational for listed conditions. 2 associated trial(s) and 0 study reference(s) in current data. Review primary sources and consult specialists before use.
Related Conditions
Long COVID (no page yet) · ME/CFS (no page yet)
Clinical Trials
2 trial(s) registered
NCT05967052: Investigation of Treating Chronic Fatigue Syndrome After COVID With Pharmacotherapy (Pregabalin) or Complex Rehabilitation PHASE2 TERMINATED
NCT05817032: Effect of Telerehabilitation Practice in Long COVID-19 Patients NA UNKNOWN
Key Studies / References